Abstract

Moxifloxacin in Dianeal 1.36% Peritoneal Dialysis Solution

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2007 - Hormone Replacement Therapy

Page(s): 331

Download in electronic PDF format for $75

Abstract

A formulation for preparing Moxifloxacin in Dianeal 1.36% Peritoneal Dialysis Solution. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2007 Pg. 331	Moxifloxacin in Dianeal 1.36% Peritoneal Dialysis Solution Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 415	Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose Author(s): Allen Loyd V Jr
Jul/Aug 1999 Pg. 306	Vancomycin and Ceftazidime in Peritoneal Dialysis Solution Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 236-238	Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration Author(s): Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C
Jul/Aug 2015 Pg. 329	Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection Author(s): Allen Loyd V
Jul/Aug 2009 Pg. 337	Moxifloxacin 20-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 53-55	Quality Control Analytical Methods: Testing of Electrolytes Solutions Author(s): Vu Nicole
Nov/Dec 2007 Pg. 520-524	Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Nov/Dec 2017 Pg. 481-486	Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 137-141	Formulation and Stability of Solutions Author(s): Akers Michael J
Jan/Feb 2001 Pg. 38	Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 270-280	Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Author(s): Logomasini Mark A, Stout Richard R, Ron Marcinkoski
Sep/Oct 2010 Pg. 421	Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 346-349	Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin Author(s): Baker Daniel S, Waldrop Bruce, Arnold John
Sep/Oct 2008 Pg. 460-462	Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Author(s): Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
Jan/Feb 2004 Pg. 46-48	Basics of Compounding for Disorders of the External Ear Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 41-45	Formulation and Stability of Solutions Author(s): Akers Michael J
Sep/Oct 2016 Pg. 438-439	A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution Author(s): Tannous Elias, Tal Yana, Amarny Kamal
Jul/Aug 2017 Pg. 301-308	Basics of Sterile Compounding: Excipients Used in Injections Author(s): Akers Michael J